Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 05 - 17 save search
Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-17 (Crawled : 23:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 28.36%
H: 38.89%
C: 36.36%
financial results results
Gain Therapeutics to Participate in Upcoming Virtual Investor Conferences in May
Published: 2021-05-17 (Crawled : 21:00) - biospace.com/
GANX | $3.14 -0.63% -0.64% 81K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.97%
C: 1.84%
conference
Acer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 21:00) - acertx.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.87%
H: 4.76%
C: -0.37%
financial results results
Spero Therapeutics Awarded up to $23 Million by the National Institute of Allergy and Infectious Diseases to Support the Development of SPR206
Published: 2021-05-17 (Crawled : 20:00) - globenewswire.com
SPRO | $1.5 2.04% 2.0% 210K
|
Health Technology
|
| O: 0.52%
H: 6.83%
C: 2.45%
disease infectious disease
515SM, Associate Scientist / Senior Research Associate, Bioassay Development
Published: 2021-05-17 (Crawled : 19:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M
|
Health Technology
|
| O: 1.01%
H: 7.41%
C: 1.19%
research
516LF, Scientist / Associate Scientist, Cellular Reprogramming & Engineering
Published: 2021-05-17 (Crawled : 19:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M
|
Health Technology
|
| O: 1.01%
H: 7.41%
C: 1.19%
517KY, Scientist, Process Development
Published: 2021-05-17 (Crawled : 19:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M
|
Health Technology
|
| O: 1.01%
H: 7.41%
C: 1.19%
518SM, Information Security Engineer
Published: 2021-05-17 (Crawled : 19:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M
|
Health Technology
|
| O: 1.01%
H: 7.41%
C: 1.19%
security
519SR, Shipping and Receiving Associate
Published: 2021-05-17 (Crawled : 19:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M
|
Health Technology
|
| O: 1.01%
H: 7.41%
C: 1.19%
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
Published: 2021-05-17 (Crawled : 13:15) - ir.stockpr.com
CYTH | $1.25 2.46% 2.4% 31K
|
Professional, Scientific, and T...
|
| O: 4.71%
H: 0.0%
C: -3.96%
financial results results
Makana Therapeutics Announces the Appointment of Dr. Kurt Dasse to its Board of Directors
Published: 2021-05-17 (Crawled : 13:15) - biospace.com/
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -0.26%
H: 0.3%
C: -1.07%
DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke
Published: 2021-05-17 (Crawled : 13:15) - biospace.com/
DMAC | News | $2.58 8.86% 8.14% 41K
|
Health Technology
|
| O: 8.31%
H: 2.27%
C: -2.7%
fda clearance fda stroke phase 2 phase 2/3 trial application clearance
Turning Point Therapeutics Names Kumar Srinivasan as Executive Vice President, Chief Business Officer
Published: 2021-05-17 (Crawled : 13:15) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -1.79%
H: 4.76%
C: 3.44%
ESPERION Appoints Sheldon Koenig as President and CEO
Published: 2021-05-17 (Crawled : 13:15) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
ESPR | $1.83 -4.19% -4.37% 3.7M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -8.1%
ceo leo
Liminal BioSciences Enters into Agreement with Kedrion to Divest Its Plasma Collection and Plasma-Derived Therapeutics Business
Published: 2021-05-17 (Crawled : 13:00) - biospace.com/
LMNL | $8.5 0.12% 0.12% 0
|
Health Technology
|
| O: 1.64%
H: 14.71%
C: 2.07%
F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 13:00) - globenewswire.com
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -2.59%
H: 19.53%
C: 5.31%
financial results results
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2021, and Provides Business Update
Published: 2021-05-17 (Crawled : 13:00) - globenewswire.com
GALT | $3.4 0.0% 160K
|
Health Technology
|
| O: -0.71%
H: 8.81%
C: 4.29%
financial results results galectin-3
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021
Published: 2021-05-17 (Crawled : 13:00) - globenewswire.com
SMMT A | $3.58 1.13% 1.12% 1.4M
|
Health Technology
|
| O: 11.53%
H: 23.14%
C: 13.52%
financial results results
Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab
Published: 2021-05-17 (Crawled : 13:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 1.41%
H: 4.59%
C: 4.56%
covid lenzilumab covid-19
ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield
Published: 2021-05-17 (Crawled : 12:15) - biospace.com/
ADCT | $4.96 11.71% 1.41% 1.2M
|
Health Technology
|
| O: 0.05%
H: 3.34%
C: 0.85%
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.